NZ218473A - Calcitonin derivatives and pharmaceutical compositions - Google Patents
Calcitonin derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ218473A NZ218473A NZ218473A NZ21847386A NZ218473A NZ 218473 A NZ218473 A NZ 218473A NZ 218473 A NZ218473 A NZ 218473A NZ 21847386 A NZ21847386 A NZ 21847386A NZ 218473 A NZ218473 A NZ 218473A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical compositions
- calcitonin derivatives
- calcitonin
- derivatives
- pharmaceutical
- Prior art date
Links
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical class N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3542859 | 1985-12-04 | ||
| DE3614784 | 1986-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ218473A true NZ218473A (en) | 1990-03-27 |
Family
ID=25838500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ218473A NZ218473A (en) | 1985-12-04 | 1986-12-02 | Calcitonin derivatives and pharmaceutical compositions |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4758550A (forum.php) |
| JP (1) | JPH085916B2 (forum.php) |
| KR (1) | KR880006263A (forum.php) |
| AU (1) | AU600242B2 (forum.php) |
| BE (1) | BE905849A (forum.php) |
| CH (1) | CH671229A5 (forum.php) |
| DK (1) | DK580186A (forum.php) |
| ES (1) | ES2012510A6 (forum.php) |
| FI (1) | FI864939A7 (forum.php) |
| FR (1) | FR2590902B1 (forum.php) |
| GB (1) | GB2184729B (forum.php) |
| GR (1) | GR862836B (forum.php) |
| HU (1) | HUT44794A (forum.php) |
| IL (1) | IL80846A0 (forum.php) |
| IT (1) | IT1214754B (forum.php) |
| LU (1) | LU86697A1 (forum.php) |
| NL (1) | NL8602950A (forum.php) |
| NZ (1) | NZ218473A (forum.php) |
| PT (1) | PT83835B (forum.php) |
| SE (1) | SE8605189L (forum.php) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0298474B1 (en) * | 1987-07-08 | 1992-11-19 | Mitsubishi Petrochemical Co., Ltd. | Novel calcitonin derivative and salt thereof |
| AU609911B2 (en) * | 1987-12-16 | 1991-05-09 | Rorer International (Overseas) Inc. | 8-glycine,16-x, des-19-leucine-calcitonin |
| GB2218102B (en) * | 1988-04-08 | 1992-09-16 | Sandoz Ltd | Calcitonin peptide derivatives |
| AU629552B2 (en) * | 1988-06-16 | 1992-10-08 | Teijin Limited | S-sulfonated calcitonin derivatives |
| US5026825A (en) * | 1988-09-08 | 1991-06-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Intranasal calcitonin formulations |
| ES2061809T3 (es) * | 1988-11-24 | 1994-12-16 | Mitsubishi Petrochemical Co | Un metodo para preparar un derivado de calcitonina. |
| EP0460064A4 (en) * | 1989-02-23 | 1992-04-01 | Rorer International (Holdings) Inc. | Therapeutic aerosol formulations |
| US5204326A (en) * | 1989-03-16 | 1993-04-20 | Otsuka Pharmaceutical Co., Ltd. | Polypeptide derivatives and calcium metabolism improving agent |
| KR0141973B1 (ko) * | 1989-04-21 | 1998-06-15 | 쓰무라 아끼라 | 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제 |
| US5364840A (en) * | 1989-12-05 | 1994-11-15 | Vical, Inc. | Synthetic calcitonin peptides |
| US5175146A (en) * | 1989-12-05 | 1992-12-29 | Vical, Inc. | Synthetic calcitonin peptides |
| CS89491A3 (en) * | 1990-04-09 | 1992-01-15 | Chugai Pharmaceutical Co Ltd | Hybrid calcitonin |
| ES2051647B1 (es) * | 1992-12-10 | 1995-01-16 | Lipotec Sa | Procedimiento para la preparacion de calcitonina de salmon. |
| US5710244A (en) * | 1992-12-31 | 1998-01-20 | Labroo; Virender M. | Derivatized calcitonins |
| EP0677062A1 (en) * | 1992-12-31 | 1995-10-18 | Zymogenetics, Inc. | Derivatized calcitonins |
| AU1919595A (en) * | 1994-02-09 | 1995-08-29 | Brigham And Women's Hospital | Gel-forming polypeptide derivatives |
| EP0726075A1 (en) * | 1995-02-08 | 1996-08-14 | Therapicon Srl | Pharmaceutical non-inorganic saline solutions for endonasal administration |
| KR960031478A (ko) * | 1995-02-14 | 1996-09-17 | 성재갑 | 유비퀴틴 융합 인간 칼시토닌의 정제방법 |
| US6034064A (en) * | 1995-04-07 | 2000-03-07 | Hoechst Pharmaceuticals & Chemicals K.K. | Peptides and therapeutic agent for autoimmune diseases containing the same |
| US5721207A (en) * | 1995-04-18 | 1998-02-24 | Innapharma, Inc. | Method for treatment of pain |
| ATE491723T1 (de) | 1998-02-13 | 2011-01-15 | Amylin Pharmaceuticals Inc | Neue verbindungen mit gemischter amylin aktivität |
| US6936584B1 (en) | 1998-02-13 | 2005-08-30 | Amylin Pharmaceuticals, Inc. | Mixed amylin activity compounds |
| BRPI0708299A2 (pt) * | 2006-02-27 | 2011-05-24 | Univ Leland Stanford Junior | composições e métodos para o transporte de moléculas com propriedades melhoradas de liberação através de barreiras biológicas |
| JP6571333B2 (ja) * | 2011-12-09 | 2019-09-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 改変ミニヘプシジンペプチドおよびその使用方法 |
| US9816066B2 (en) | 2012-04-24 | 2017-11-14 | The Regents Of The University Of California | Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3926938A (en) * | 1974-08-12 | 1975-12-16 | Armour Pharma | Synthesis of salmon calcitonin |
| JPS51128993A (en) * | 1975-05-01 | 1976-11-10 | Tanpakushitsu Kenkyu Shiyoureikai | Process for preparing new polypeptides |
| GB1592969A (en) * | 1976-09-13 | 1981-07-15 | Armour Pharma | Hentriacontapeptides and preparation thereof |
| JPS60500054A (ja) * | 1983-02-15 | 1985-01-17 | ア−マ−・フア−マシユ−テイカル・カンパニ− | デス−アスパラギン−３−カルシトニン |
| US4663309A (en) * | 1983-06-29 | 1987-05-05 | University Patents, Inc. | Novel peptide hormones with calcitonin-like activity |
| GB8327346D0 (en) * | 1983-10-12 | 1983-11-16 | Morris H R | Peptide |
| US4497732A (en) * | 1983-10-21 | 1985-02-05 | Armour Pharmaceutical Company | 1A-Endo-glycine-calcitonin |
| US4537716A (en) * | 1983-12-05 | 1985-08-27 | Armour Pharmaceutical Co. | Des-serine2 or des-glycine2 -leucine22 calcitonin |
| US4622386A (en) * | 1985-03-28 | 1986-11-11 | Armour Pharmaceutical Company | [1,7-di-alanine]calcitonin |
| US4658014A (en) * | 1985-12-20 | 1987-04-14 | Kempe Tomas G | Synthetic peptides with calcitonin-like activity |
| AU7468687A (en) * | 1987-06-23 | 1989-01-05 | Armour Pharmaceutical Company | (n-acyl, 1,7-di-alanine) calcitonin |
-
1986
- 1986-11-20 NL NL8602950A patent/NL8602950A/nl not_active Application Discontinuation
- 1986-11-20 HU HU864812A patent/HUT44794A/hu unknown
- 1986-11-25 CH CH4717/86A patent/CH671229A5/de not_active IP Right Cessation
- 1986-11-28 PT PT83835A patent/PT83835B/pt not_active IP Right Cessation
- 1986-12-02 GR GR862836A patent/GR862836B/el unknown
- 1986-12-02 IL IL80846A patent/IL80846A0/xx unknown
- 1986-12-02 GB GB8628739A patent/GB2184729B/en not_active Expired - Lifetime
- 1986-12-02 NZ NZ218473A patent/NZ218473A/xx unknown
- 1986-12-02 DK DK580186A patent/DK580186A/da not_active Application Discontinuation
- 1986-12-03 FI FI864939A patent/FI864939A7/fi not_active Application Discontinuation
- 1986-12-03 BE BE1/011581A patent/BE905849A/fr not_active IP Right Cessation
- 1986-12-03 LU LU86697A patent/LU86697A1/fr unknown
- 1986-12-03 JP JP61288629A patent/JPH085916B2/ja not_active Expired - Lifetime
- 1986-12-03 FR FR8616885A patent/FR2590902B1/fr not_active Expired - Fee Related
- 1986-12-03 AU AU66061/86A patent/AU600242B2/en not_active Ceased
- 1986-12-03 US US06/937,580 patent/US4758550A/en not_active Expired - Fee Related
- 1986-12-03 ES ES8603267A patent/ES2012510A6/es not_active Expired - Lifetime
- 1986-12-03 KR KR860010384A patent/KR880006263A/ko not_active Ceased
- 1986-12-03 SE SE8605189A patent/SE8605189L/xx not_active Application Discontinuation
- 1986-12-04 IT IT8648701A patent/IT1214754B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| IT1214754B (it) | 1990-01-18 |
| LU86697A1 (fr) | 1987-07-24 |
| US4758550A (en) | 1988-07-19 |
| AU600242B2 (en) | 1990-08-09 |
| DK580186D0 (da) | 1986-12-02 |
| DK580186A (da) | 1987-06-05 |
| IL80846A0 (en) | 1987-03-31 |
| JPS62132898A (ja) | 1987-06-16 |
| PT83835A (en) | 1986-12-01 |
| FI864939A7 (fi) | 1987-06-05 |
| IT8648701A0 (it) | 1986-12-04 |
| BE905849A (fr) | 1987-06-03 |
| CH671229A5 (forum.php) | 1989-08-15 |
| FI864939A0 (fi) | 1986-12-03 |
| JPH085916B2 (ja) | 1996-01-24 |
| GR862836B (en) | 1987-04-02 |
| FR2590902B1 (fr) | 1994-12-23 |
| PT83835B (pt) | 1989-06-30 |
| GB2184729B (en) | 1990-07-25 |
| AU6606186A (en) | 1987-06-11 |
| ES2012510A6 (es) | 1990-04-01 |
| SE8605189L (sv) | 1987-06-05 |
| KR880006263A (ko) | 1988-07-22 |
| SE8605189D0 (sv) | 1986-12-03 |
| GB8628739D0 (en) | 1987-01-07 |
| HUT44794A (en) | 1988-04-28 |
| FR2590902A1 (fr) | 1987-06-05 |
| GB2184729A (en) | 1987-07-01 |
| NL8602950A (nl) | 1987-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ216793A (en) | Phenethanolaminotetraline derivatives and pharmaceutical compositions | |
| NZ218473A (en) | Calcitonin derivatives and pharmaceutical compositions | |
| NZ216678A (en) | Heterocyclic substituted-phenoxyalkyl-isoxazoles and -furans and pharmaceutical compositions | |
| NZ216547A (en) | Piperazine derivatives and pharmaceutical compositions | |
| NZ216951A (en) | Pyrimidine derivatives and pharmaceutical compositions | |
| NZ211031A (en) | 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions | |
| NZ216389A (en) | Pyrimidines and pharmaceutical compositions | |
| NZ217597A (en) | Urea derivatives and pharmaceutical compositions | |
| IL74865A0 (en) | 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
| NZ217537A (en) | Benzimidazoles and pharmaceutical compositions | |
| IL78872A0 (en) | Morphinan derivatives and pharmaceutical compositions containing them | |
| IL79376A0 (en) | Substituted di-t-butylphenols and pharmaceutical compositions containing them | |
| IL76188A (en) | 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them | |
| NZ214821A (en) | Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions | |
| NZ215871A (en) | Fluorinated phenylalkyl-triazole derivatives and pharmaceutical compositions | |
| NZ217220A (en) | Guanine derivatives and pharmaceutical compositions | |
| NZ217078A (en) | N-piperidyl-benzamide derivatives and pharmaceutical compositions | |
| IL86711A0 (en) | 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them | |
| NZ210818A (en) | 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions | |
| NZ215753A (en) | Phenethanolamine derivatives and pharmaceutical compositions | |
| NZ225466A (en) | 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof | |
| NZ216720A (en) | Diazinylpiperidine derivatives and pharmaceutical compositions | |
| NZ215070A (en) | Imidazole-indoles and pharmaceutical compositions | |
| GB2167414B (en) | Flavolignan derivatives and pharmaceutical compositions containing them | |
| IL79003A0 (en) | Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them |